0001144204-12-020459.txt : 20120405 0001144204-12-020459.hdr.sgml : 20120405 20120405200142 ACCESSION NUMBER: 0001144204-12-020459 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120405 FILED AS OF DATE: 20120405 DATE AS OF CHANGE: 20120405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliviero James F III CENTRAL INDEX KEY: 0001434718 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 12746896 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 v308674_4.xml OWNERSHIP DOCUMENT X0305 4 2012-04-05 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001434718 Oliviero James F III C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 0 1 0 0 Chief Financial Officer Common Stock 2012-04-05 4 S 0 5458 1.601 D 176560 D Sale of a total of 5,458 shares of common stock was made in order to satisfy Mr. Oliviero's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on April 2, 2012. Mr. Oliviero had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Of the 176,560 shares, 71,853 are shares of restricted stock. /s/ James F. Oliviero, III 2012-04-05